Gaudium IVF And Women Health Ltd
Thu 18/06/2026,15:14:12 | NSE : GAUDIUMIVF
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 106.59
Previous Close
₹ 104.50
Volume
52153
Mkt Cap ( Rs. Cr)
₹775.84
High
₹ 106.59
Low
₹ 106.59
52 Week High
₹ 133.00
52 Week Low
₹ 69.18
Book Value Per Share
₹ 20.92
Dividend Yield
0.00
Face Value
₹ 5.00
What’s Your Call?
Collective community sentiment on Gaudium IVF And Women Health Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
128.17
3460
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
3460
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Gaudium IVF And Women Health Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Gaudium IVF & Women - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Gaudium IVF & Women Q4 net profit up 24.48% at Rs 7.73 cr
-
Gaudium IVF & Women - Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026
-
Gaudium IVF & Women - Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Resul
-
Gaudium IVF & Women - Outcome of Board Meeting
-
Gaudium IVF & Women - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2
-
Gaudium IVF & Women - General Updates
-
Gaudium IVF & Women - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Gaudium IVF & Women - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Sta
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Gaudium IVF & Women - Monitoring Agency Report
-
Gaudium IVF & Women - Price movement
-
Gaudium IVF & Women - Clarification On Price Movement
-
Gaudium IVF & Women has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Gaudium IVF & Women - Clarification sought from Gaudium IVF and Women Health Ltd
-
Gaudium IVF & Women - Price movement
-
Gaudium IVF & Women - Updates
-
Gaudium IVF & Women - Intimation Regarding Change Of Corporate Identification Number Of The Company
-
Gaudium IVF & Women - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Gaudium IVF & Women - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Gaudium IVF & Women - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Gaudium IVF & Women - Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vi
-
Gaudium IVF & Women - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Gaudium IVF & Women - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2
-
Gaudium IVF & Women - Press Release
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Gaudium IVF & Women - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Gaudium IVF & Women - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 20
-
Gaudium IVF & Women - Trading Window
-
Gaudium IVF & Women - Press Release
-
Gaudium IVF & Women - Copy of Newspaper Publication
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Gaudium IVF & Women - Announcement under Regulation 30 (LODR)-Change in Management
-
Gaudium IVF & Women - Appointment
-
Gaudium IVF & Women - Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Res
-
Gaudium IVF & Women - Outcome of Board Meeting
-
Gaudium IVF & Women - Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December
Key fundamentals
Evaluate the intrinsic value of Gaudium IVF And Women Health Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | |
|---|---|---|---|---|---|
| Assets | 170.3643 | 64.3678 | 42.3871 | 32.5854 | |
| Liabilities | 170.3643 | 64.3678 | 42.3871 | 32.5854 | |
| Equity | 36.3934 | 30.6972 | 0.9902 | 0.9902 | |
| Gross Profit | 34.5659 | 27.8643 | 18.7416 | 19.6389 | |
| Net Profit | 22.2877 | 18.5876 | 9.9275 | 13.2626 | |
| Cash From Operating Activities | 7.2734 | 8.4365 | 3.4675 | 0 | |
| NPM(%) | 31.13 | 31.5 | 21.61 | 30.13 | |
| Revenue | 71.5785 | 59.0016 | 45.9381 | 44.0142 | |
| Expenses | 37.0126 | 31.1373 | 27.1965 | 24.3753 | |
| ROE(%) | 14.63 | 12.2 | 6.51 | 8.7 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Gaudium IVF And Women Health Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 711.00 | 0.55 | 0.00 | 57.70 | -26.19 | 0.70 |
| Lotus Eye Hospital and Institute Ltd | 132.30 | -2.92 | 4410.00 | 210.25 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.70 | 3.36 | 24.84 | 1318.97 | 15.96 | 0.00 |
| Astec Lifesciences Ltd | 792.50 | 0.39 | 0.00 | 198.27 | -363.14 | 0.00 |
Company Info
Our Company was originally incorporated in the name of "Gaudium IVF and Women Health Private Limited" as a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated March 24, 2015 issued by the RoC, Delhi and Haryana. Subsequently, our Company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of our Shareholders held on September 28, 2024 and consequently, the name of our Company was changed to `Gaudium IVF and Women Health Limited', and a fresh certificate of incorporation dated October 24, 2024 was issued by the Central processing center.Major Events and Milestones:2015- Incorporation of the Company2019- Company started Gaudium Hospital2021- Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna:* Janakpuri Center - opened in 2009* Greater Kailash Center - opened in 2016* Patna Center - opened in 2019- Company started Mumbai Center (Maharashtra)2023- Acquired Gaudium Brand- Acquired 100% shares of Gaudium International Private Limited- Acquired Gaudium Bawa Ludhiana Center**- Company started Bangalore Centre (Karnataka)2024- Company started Srinagar Centre (Jammu & Kashmir)- Conversion of company from Private to Public
Our Company was originally incorporated in the name of "Gaudium IVF and Women Health Private Limited" as a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated March 24, 2015 issued by the RoC, Delhi and Haryana. Subsequently, our Company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of our Shareholders held on September 28, 2024 and consequently, the name of our Company was changed to `Gaudium IVF and Women Health Limited', and a fresh certificate of incorporation dated October 24, 2024 was issued by the Central processing center.Major Events and Milestones:2015- Incorporation of the Company2019- Company started Gaudium Hospital2021- Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna:* Janakpuri Center - opened in 2009* Greater Kailash Center - opened in 2016* Patna Center - opened in 2019- Company started Mumbai Center (Maharashtra)2023- Acquired Gaudium Brand- Acquired 100% shares of Gaudium International Private Limited- Acquired Gaudium Bawa Ludhiana Center**- Company started Bangalore Centre (Karnataka)2024- Company started Srinagar Centre (Jammu & Kashmir)- Conversion of company from Private to Public
Read More
Parent Organisation
Gaudium IVF And Women Health Ltd.
Founded
24/03/2015
Managing Director
Dr.Manika Khanna
NSE Symbol
GAUDIUMIVFBE
FAQ
The current price of Gaudium IVF And Women Health Ltd is ₹ 106.59.
The 52-week high for Gaudium IVF And Women Health Ltd is ₹ 106.59 and the 52-week low is ₹ 106.59.
The market capitalization of Gaudium IVF And Women Health Ltd is currently ₹ 775.84. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Gaudium IVF And Women Health Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Gaudium IVF And Women Health Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gaudium IVF And Women Health Ltd shares.
The CEO of Gaudium IVF And Women Health Ltd is Dr.Manika Khanna, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
